Role of in vitamin D in irritable bowel syndrome

doi:10.12998/wjcc.v11.i12.2677

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10359)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

351

WORD

HTML

7701

Figures (1-2)

523

Sum=8598

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

417

Download

1326

Sum=1743

Apr 26, 2023 (publication date) through Mar 2, 2026

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Clin Cases. Apr 26, 2023; 11(12): 2677-2683
Published online Apr 26, 2023. doi: 10.12998/wjcc.v11.i12.2677

Role of in vitamin D in irritable bowel syndrome

Xiao-Lan Yu, Qi-Qi Wu, Lian-Ping He, Yong-Feng Zheng

Xiao-Lan Yu, Qi-Qi Wu, Lian-Ping He, School of Medicine, Taizhou University, Jiaojiang 318000, Zhejiang Province, China

Yong-Feng Zheng, Department of Anesthesiology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang 212002, Jiangsu Province, China

Author contributions: Yu XL generated the figure and wrote the first draft; Wu QQ and Zheng YF contributed to the writing and editing of the manuscript; He LP conceptualized the topic and proofread the manuscript; All authors provided supervision and approved the submission of this minireview.

Conflict-of-interest statement: All the authors report having no relevant conflicts of interest for this article.

Corresponding author: Yong-Feng Zheng, MD, Doctor, Senior Researcher, Department of Anesthesiology, Affiliated People’s Hospital of Jiangsu University, No. 8 Dianli Road, Runzhou District, Zhenjiang 212002, Jiangsu Province, China. zhengyf.163@163.com

Received: February 17, 2023
Peer-review started: February 17, 2023
First decision: March 10, 2023
Revised: March 12, 2023
Accepted: March 24, 2023
Article in press: March 24, 2023
Published online: April 26, 2023
Processing time: 67 Days and 14.1 Hours

Core Tip

Core Tip: Irritable bowel syndrome (IBS) is a common chronic functional gastrointestinal disorder affecting 10%-22% of adults. Its development is related to the gut microbiota, and the inflammatory and immune responses triggered by the gut microbiota can lead to IBS. Vitamin D (VD) is effective in treating IBS by improving gut microbiota, immune regulation, and anti-inflammatory effects. It is necessary to carry out epidemiological studies on the relationship between VD and IBS, clinical studies on the efficacy of supplementing VD to improve IBS, and animal studies on the mechanism of VD improving IBS. This paper discussed the relationship between VD and IBS.